The 10 new flu-related deaths in children bring the season's total to 226, the most since 2009-10.
The loss of activity is equivalent to 15% of the US population becoming completely immobile for 1 day.
Adult COVID-19 patients also infected with the flu are 4 times more likely to need mechanical ventilation and 2.4 times more likely to die.
The roadmap offers a powerful opportunity to leverage advances in vaccine science to better protect against influenza, including pandemic flu.
The Influenza Vaccines Roadmaps Initiative newsletter highlights recent news, research, and events pertaining to influenza vaccine R&D.
A database of novel vaccine candidates that are designed to provide broader and more durable protection against influenza viruses.
Help support our work on influenza. Advance the work of CIDRAP in public health preparedness and emerging infectious disease response.
Receive the latest infectious disease information.
Editor's note: This story was revised Jan 8 to correct information about the location of the test's manufacturer.
(CIDRAP News) A single test that can identify up to 12 different respiratory viruses, including three kinds of influenza, from one sample has won the Food and Drug Administration's (FDA's) approval.
Editor's Note: CIDRAP's Promising Practices: Pandemic Influenza Preparedness Tools online database showcases peer-reviewed practices, including useful tools to help others with their planning. This article is one of a biweekly series exploring the development of these practices. We hope that describing the process and context of these practices enhances pandemic planning.
(CIDRAP News) – Experts from the US Centers for Disease Control and Prevention (CDC) and the National Influenza Vaccine Summit (NIVS) in a teleconference today urged clinicians to consider extending their seasonal flu vaccination efforts through March and shared strategies for immunizing more patients during office visits.
(CIDRAP News) – The US Department of Health and Human Services (HHS) has released a toolkit to help community leaders educate their constituents about steps they can take to prepare for an influenza pandemic.
(CIDRAP News)
Introductory remarksJohn Barry's commentary
(CIDRAP News) The US Food and Drug Administration's (FDA's) Pediatric Advisory Committee voted today to recommend stronger label warnings for two antiviral influenza medicationsoseltamivir and zanamivirthat have been linked to reports of neuropsychiatric problems in children and teens, mainly in Japan.
Oseltamivir already carries a warning, but zanamivir currently carries no warning about reported neuropsychiatric effects.
(CIDRAP News) A World Health Organization (WHO) group that recently met to work out an agreement to ease the global sharing of H5N1 avian influenza viruses failed to resolve the issue, but signaled that work on the issues would continue.
Editor's Note: This article is one of an occasional series exploring the development of public health practices included in the CIDRAP Promising Practices: Pandemic Influenza Preparedness Tools online database. We hope that describing the process and context that drove development of these practices serves as a valuable tool for pandemic planning.
